Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bone Biologics Corp

0.6850
-0.0150-2.14%
Volume:7.81K
Turnover:5.24K
Market Cap:2.24M
PE:-0.14
High:0.6850
Open:0.6740
Low:0.6556
Close:0.7000
Loading ...
Apr 15, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 09, 2020

Major Issues Report

8-K - Current report
Nov 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 25, 2019

Major Issues Report

8-K - Current report
Aug 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 17, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 28, 2019

Major Issues Report

8-K - Current report
Jun 21, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 24, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2019

Major Issues Report

8-K - Current report
Mar 29, 2019

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 25, 2019

Major Issues Report

8-K - Current report
Nov 16, 2018

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 14, 2018

Major Issues Report

8-K - Current report
Aug 14, 2018

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]